# Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer

> **NCT01205672** · EARLY_PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 21 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01205672
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-16
- **Primary completion:** 2017-05-28
- **Final completion:** 2017-05-28
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01205672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01205672, "Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01205672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*